- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Accelrys, Inc. (NASDAQ:ACCL) today announced that it will report financial results for the quarter ended December 31, 2006 after the NASDAQ Market closes on Thursday, February 1, 2007. The Company will conduct a conference call and an audio webcast at 5:00 p.m. ET on the same day.
Conference Call Information
Domestic callers: 1 866-831-6243
International callers: +1 617-213-8855
Webcast information: http://ir.accelrys.com/
The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at www.fulldisclosure.com, Thomson/CCBN's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents (www.streetevents.com).
A replay of the conference call, which can be accessed by dialing toll-free 1-888-286-8010, and outside the U.S. +1-617-801-6888, will be available beginning 7:00 p.m. ET on February 1, 2007 through 5:00 p.m. ET on May 1, 2007. The access code for the replay is 37598796.
About About Accelrys, Inc.
Accelrys, Inc. (ACCL) is a leading provider of software for computation, simulation, and the management and mining of scientific data used by biologists, chemists and materials scientists, including nanotechnology researchers for product design as well as drug discovery and development. Accelrys technology and services are designed to meet the needs of today's leading research organizations. The Company is headquartered in San Diego, California. Its materials research and development team is based at its European Headquarters and Centre of Excellence in Cambridge, UK. For more information see http://www.accelrys.com/ .
For more information, please click here
Rick Russo, 858-799-5200
Copyright © Business WireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Nanotech Grants Options September 22nd, 2016
Arrowhead Pharmaceuticals to Present at Upcoming September Conferences September 1st, 2016
Industrial Nanotech, Inc. Provides Shareholder Update August 22nd, 2016
Chad Mirkin receives nanotechnology prize in Russia October 26th, 2016
Imaging where cancer drugs go in the body could improve treatment October 26th, 2016
Nanometrics Reports Second Quarter 2016 Financial Results July 26th, 2016
Nanobiotix revenue for Q2 2016 July 14th, 2016